Document is current
Any future updates will be listed below
-
Authors
Murota, Hiroyuki
Nakahara, Takeshi
Wang, Xinyu
Matsukawa, Miyuki
Takeda, Hiroe
Kondo, Tomohiro
Yamato, Kentaro https://orcid.org/0000-0002-5027-6289
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 18 March 2025
First Online: 29 March 2025
Declarations
:
: This study and medical writing assistance were funded by Otsuka Pharmaceutical Co., Ltd. Hiroyuki Murota has received consulting fees and/or speaker honoraria from Maruho Co., Ltd., Kaken Pharmaceutical Co., Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Kyowa Kirin Co., Ltd., Torii Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., AbbVie GK, and Otsuka Pharmaceutical Co., Ltd. Takeshi Nakahara has received consulting fees and/or speaker honoraria from Mitsubishi Tanabe Pharma Corp., Taiho Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Maruho Co., Ltd., Sanofi K.K., AbbVie GK, Eli Lilly Japan K.K., Sun Pharma Japan Ltd., and Otsuka Pharmaceutical Co., Ltd. Miyuki Matsukawa, Hiroe Takeda, Tomohiro Kondo, and Kentaro Yamato are employees of Otsuka Pharmaceutical Co., Ltd. Xinyu Wang was employed by Otsuka Pharmaceutical Co., Ltd., during the conduct of the study and reports no conflicts of interest. Some of the authors are employees of Otsuka Pharmaceutical Co., Ltd., but the results were objectively evaluated using legitimate methods.
: This study is based on previously conducted studies and does not contain any new studies with human participants performed by any of the authors.
